TECNOTREE
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, is thrilled to announce a ground-breaking partnership with BytePlus, the enterprise arm of Bytedance, to revolutionise wholesale enterprise monetization through Tecnotree Moments campaign management for CSPs. This collaboration marks a significant milestone in B2B2X digital ecosystem management, showcasing a bold step towards enhanced AI and API monetization strategies for CSPs worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226979665/en/
(Graphic: Business Wire)
Tecnotree Moments, leveraging its expertise in telco partner ecosystem monetisation, has partnered with Byteplus, in digital media and distribution, introducing cutting-edge solutions that drive value and growth for CSPs. The partnership underscores Tecnotree Moments's commitment to delivering AI solutions such as channel personalization and interactive experiences on a unified telecom led customer data platform, enabling CSPs to unlock new enterprise revenue streams through AIML and Multi-AIML model management for goal based learning delivering hyper-personalisation in video, music and ARVR advertising for the 3 dimensional 5G world.
The reseller API integration will see Tecnotree Moments reselling Byteplus’s advanced media technology on Moments’ campaign and marketplace to a ecosystem of digital services partners through CSPs. Tecnotree will be integrating wholesale advertising, content personalisation, and AIML recommendation models, to help CSPs in B2B2X enterprise monetisation across telecom, social media and digital channels. The comprehensive monetization suite, while enhancing customer experience will unlock new revenue streams for Telcos beyond data bundling, empowering CSPs to maximize revenue opportunities through Cost Per Click (CPC), Cost Per Mille (CPM) models and other cloud based subscription models for advertising.
Commenting on the partnership, Prianca Ravichander, CMO and Global Head of Partnerships of Tecnotree Corporation, said, “The 5G AI future is 3 dimensional with the digital landscape rapidly evolving, there is an opportunity to help CSPs monetize hyper-personalisation for enterprises on the Tecnotree Moments communication as a service platform. We are thrilled about the collaboration and its potential to reshape channel personalisation through telcos. By combining Tecnotree Moments’ channel personalisation platform for CSPs with Byteplus’s advanced creator tools and content recommendation technology for guaranteed uplift, we aim to empower creators, enterprises and telcos to thrive in the new digital economy.”
Charlie Sung, Global Head Partnership & Ecosystem, ByteDance and BytePlus said "Our collaboration with Tecnotree Moments represents a significant step forward in our mission to revolutionize digital monetization and our commitment to the region. Together, we look forward to empowering CSPs with innovative solutions, capitalize on the growing demand for personalization, and position ourselves for success in today’s digital economy”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About BytePlus
Byteplus is designed to help businesses grow and improve efficiency by providing them with cutting-edge technology solutions that are powered by ByteDance's vast knowledge and expertise accumulated through serving billions of users globally. The platform offers a range of services, including personalized recommendation algorithms, AI technologies, machine learning, video and image recognition, cloud data warehouse and content delivery. With these tools, businesses can improve their customer experience, enhance their products and services, and gain a competitive edge in the market.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226979665/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom